Inogen reports recurring developments as a respiratory medical technology company serving homecare patients with chronic respiratory conditions. Its updates focus on financial results and outlook, portable oxygen concentrators, Simeox airway clearance, stationary oxygen concentrators, and Aurora CPAP masks for obstructive sleep apnea.
Company news also covers product introductions, clinical evidence and reimbursement work, international market activity, commercial partnerships, leadership and board changes, inducement equity awards, share repurchase actions, and investor conference participation.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Inogen, Inc. (Nasdaq: INGN) is set to announce its first quarter 2023 financial results after market close on May 4, 2023. The company will host a conference call on the same day at 2:00 p.m. PT / 5:00 p.m. ET. Investors can access the call by dialing (888) 645-4404 for US callers and (862) 298-0702 for international callers. A live webcast will also be available on Inogen’s Investor Relations website at http://investor.inogen.com/, which will be archived for six months. A replay of the call will be accessible starting three hours post-call until May 11, 2023.
Inogen, Inc. (Nasdaq: INGN) announced its participation in the 22nd Annual Needham Virtual Healthcare Conference on April 19, 2023, at 12:45 p.m. ET. The event will include a live audio webcast and an archived recording accessible via the News / Events section of Inogen's Investor Relations website. As a leader in the medical technology sector, Inogen specializes in innovative respiratory products for homecare settings, focusing on portable oxygen concentrators for chronic respiratory conditions. For more details, visit www.inogen.com.